Viewing Study NCT06653803



Ignite Creation Date: 2024-10-26 @ 3:43 PM
Last Modification Date: 2024-10-26 @ 3:43 PM
Study NCT ID: NCT06653803
Status: RECRUITING
Last Update Posted: None
First Post: 2024-10-21

Brief Title: Rhomboid Intercostal Block Versus Retrolaminar Block for Postoperative Analgesia After Thoracoscopic Sympathectomy
Sponsor: None
Organization: None

Study Overview

Official Title: Ultrasound-guided Rhomboid Intercostal Block Versus Retrolaminar Block for Postoperative Analgesia After Thoracoscopic Sympathectomy A Randomized Clinical Trial
Status: RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Background Although thoracoscopic sympathectomy is made via small incisions it is associated with severe postoperative pain Both Rhomboid intercostal block RIB and Retrolaminar block RLB are recent techniques used for pain control after such procedures

Objectives To compare the effectiveness of RIB and RLB in providing postoperative analgesia after thoracoscopic sympathectomy in adult patients and their impact on the patients outcomes

Patients and Methods This prospective randomized 11 double-blind clinical trial will be carried out on 60 patients scheduled for elective thoracoscopic sympathectomy under general anesthesia at our hospital Patients will be randomly allocated into two equal groups 30 patients each and will receive in group A general anesthesia with intraoperative ipsilateral ultrasound-guided RIB whereas in group B general anesthesia with intraoperative ipsilateral ultrasound-guided RLB
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None